BMCM
BIIB icon

Burns Matteson Capital Management’s Biogen BIIB Stock Holding History

Burns Matteson Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,818
Closed -$700K – 199
2026
Q1 		$700K Sell
3,818
-101
-3% -$18.6K 0.26% 58
2025
Q4 		$690K Buy
+3,919
New +$640K 0.24% 59

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Burns Matteson Capital Management's BIIB Position: Q2 2026 in Review

Burns Matteson Capital Management sold out of Biogen (BIIB) in Q2 2026, closing a stake of 3,818 shares — an estimated $700K sold.

Burns Matteson Capital Management first reported a position in BIIB in Q4 2025 and held it in 2 quarters. The position peaked at $700K in Q1 2026. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Burns Matteson Capital Management reported no remaining Biogen position as of Q2 2026 after selling out during the quarter.
  • Burns Matteson Capital Management sold 3,818 Biogen shares in Q2 2026, an estimated $700K.
  • Burns Matteson Capital Management first reported a position in Biogen in Q4 2025 and held it in 2 quarters.
  • Burns Matteson Capital Management's Biogen position peaked at $700K in Q1 2026.
  • 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Burns Matteson Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.